$10.84 $0.27 per serving
Product analysis
Fish Oil 1400 mg provides economical EPA and DHA, which may help support healthy levels of blood fats. Their separate amounts make the serving easier to compare than the larger fish-oil weight.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The main ingredient entries do not identify the specific forms of the omega-3 fats. That limits a clear comparison of their particular quality and absorption.
Ingredient Transparency57
Separate EPA and DHA amounts are disclosed, giving a useful picture of the active fats. The total omega-3 declaration and specific forms remain less clear.
Value For Money82
The combined EPA and DHA content offers favorable value, led by economical EPA. DHA alone offers moderate value for the serving cost.
Customer Satisfaction77
Customer feedback is very positive across several hundred ratings. That provides a useful satisfaction picture without establishing cardiovascular effects.
Product Focus62
EPA and DHA give the formula a clear connection to blood-fat metabolism. Effects on blood markers do not establish prevention of major heart problems or an immediate improvement in concentration.
- Format
Softgel - Container
- 39 Softgel(s)
- Per serving
- $0.27
- Also available
Fish Oil 1200 mg$11.40- Customer rating
- 4.7 · 461 ratings
Goals
Impact
High effect
Fish Oil · 1400 mg
The declared EPA and DHA provide the main cardiovascular connection through triglyceride metabolism. Their separate active amounts, 647 mg EPA and 253 mg DHA per serving, are more informative than the 1400 mg fish-oil weight. The supplied evidence supports limited triglyceride-marker effects at studied exposures and populations, without establishing prevention of major cardiovascular events or rhythm benefits.
How this product is rated for Cardiovascular Support
Ingredient fit77
The relevant ingredients provide a focused cardiovascular connection, with their amounts and preparation details shaping expectations.
Goal fit
The relevant ingredients give this formula a clear cardiovascular focus.
Dose adequacy
The declared amounts provide substantial exposure for the ingredients counted here, without establishing a guaranteed benefit.
Pathways60
The findings are concentrated in the cardiovascular mechanisms described below; coverage does not establish prevention of heart attacks or strokes.
Depth
The strongest connection is to triglyceride metabolism.
Breadth
The broader findings cover triglyceride metabolism.
Evidence83
The supporting findings concern specific nutrients, preparations and cardiovascular markers. Their clinical limits remain relevant even where the saved findings recognize substantial support.
Evidence strength
EPA declared active provides the leading evidence connection among the ingredients counted here; its specific population and outcome limits still apply.
Studied preparation
The saved findings recognize studied preparations for the ingredients counted at meaningful amounts; this does not establish identical outcomes across products.
Formulation logic100
The counted ingredients do not require a missing partner, and no configured conflict was triggered. Amount coverage is described below.
Partner coverage
The ingredients counted here can contribute without an additional required partner.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted here meet the saved amount requirement; this is not a proven clinical effectiveness threshold.
Impact
Highest effect
EPA (Eicosapentaenoic Acid) · 647 mg
EPA provides the main connection to triglyceride metabolism, while DHA adds limited lipid and vascular-surrogate context. The serving declares 647 mg EPA and 253 mg DHA, so the active amounts can be considered without treating the whole oil mass as active omega-3. Their presence does not establish added benefit from combining them, and routine supplementation has not demonstrated general prevention of major cardiovascular events.
How this product is rated for Heart Health
Ingredient fit77
EPA and DHA provides the relevant connection, alongside ingredients serving other purposes. The declared EPA and DHA amounts provide partial exposure-based support; total fish-oil mass is not substituted for either active.
Goal fit
EPA and DHA provides the relevant connection, alongside ingredients serving other purposes.
Dose adequacy
The declared EPA and DHA amounts provide partial exposure-based support; total fish-oil mass is not substituted for either active.
Pathways54
The saved support centers on triglyceride metabolism rather than broad coverage of the assessed heart-health areas.
Depth
The saved support centers on triglyceride metabolism rather than broad coverage of the assessed heart-health areas..
Breadth
Only this area meets the saved coverage criterion; the result does not show broad support across the other areas.
Evidence100
EPA supplies the strongest recognized evidence for triglyceride-related support, without transferring prescription-therapy outcomes to this supplement.
Evidence strength
EPA supplies the strongest recognized evidence for triglyceride-related support, without transferring prescription-therapy outcomes to this supplement.
Studied preparation
The saved result recognizes the preparations of the ingredients retained for this check; that recognition does not broaden their demonstrated benefits.
Formulation logic100
The recognized ingredients do not lack a required partner, and no configured conflict was matched. The retained ingredients meet the amount check.
Partner coverage
The recognized ingredients can contribute alone or have their required partner; no missing-partner limitation was found.
Conflicts
No configured ingredient conflict was matched in the supplied facts; this check does not establish general safety.
Effective doses
All ingredients retained for this check meet its minimum amount criterion; that does not establish clinically effective dosing.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Impact
Moderate effect
Fish Oil · 1400 mg
EPA and DHA may lower some inflammation markers. A change in a blood marker does not by itself tell you whether you will notice less pain or another everyday benefit. The separate EPA and DHA amounts describe the active fatty acids; the larger fish oil amount should not be treated as an additional active dose.
How this product is rated for Inflammation
Ingredient fit64
EPA (eicosapentaenoic acid) provides the main connection to inflammation among the declared ingredients.
Goal fit
EPA (eicosapentaenoic acid) provides the main connection to inflammation among the declared ingredients.
Dose adequacy
EPA (eicosapentaenoic acid) 647 mg; DHA (docosahexaenoic acid) 253 mg per selected serving; these amounts are comparisons, not guarantees of symptom relief.
Pathways13
The main connection concerns fatty-acid processes involved in inflammation; this does not predict how much symptoms will change.
Depth
The main connection concerns fatty-acid processes involved in inflammation; this does not predict how much symptoms will change.
Breadth
The connection is concentrated in fatty-acid processes involved in inflammation, rather than a broad range of inflammatory processes.
Evidence70
EPA and DHA may lower some inflammation markers.
Evidence strength
EPA and DHA may lower some inflammation markers.
Studied preparation
The declared preparation matches the relevant ingredient context, without guaranteeing the same effect for everyone.
Formulation logic100
The relevant ingredients can act without a required partner, and no particular conflict is identified.
Partner coverage
The relevant ingredients do not require an additional partner for their described roles.
Conflicts
No particular ingredient conflict is identified for this goal.
Effective doses
EPA (eicosapentaenoic acid) 647 mg; DHA (docosahexaenoic acid) 253 mg per selected serving; these amounts are comparisons, not guarantees of symptom relief.
Impact
Situational effect
Omega-3 · NP
Impact
Moderate effect
DHA at 253 mg contributes to brain-cell membrane structure, while EPA at 647 mg relates to longer-term omega-3 nutritional support. The supplied cognitive evidence concerns repeated intake and selected groups, so these amounts do not imply an immediate improvement in concentration.
How this product is rated for Mental Focus
Ingredient fit60
DHA and EPA provide the focus-related relevance within the fish-oil ingredients. Both omega-3 amounts contribute partially relative to the saved exposure comparisons.
Goal fit
DHA and EPA provide the focus-related relevance within the fish-oil ingredients.
Dose adequacy
Both omega-3 amounts contribute partially relative to the saved exposure comparisons.
Pathways50
Support related to brain-cell structure and plasticity is the main assessed route. Only brain-cell structure and plasticity reaches the saved coverage level.
Depth
Support related to brain-cell structure and plasticity is the main assessed route.
Breadth
Only brain-cell structure and plasticity reaches the saved coverage level.
Evidence56
EPA provides the strongest saved evidence contribution at a counted amount; the scope and limitations of its evidence still apply. EPA matches the accepted preparation category; DHA is not matched to the studied preparation.
Evidence strength
EPA provides the strongest saved evidence contribution at a counted amount; the scope and limitations of its evidence still apply.
Studied preparation
EPA matches the accepted preparation category; DHA is not matched to the studied preparation.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. All 2 counted ingredients meet the saved minimum exposure comparison.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the saved assessment.
Effective doses
All 2 counted ingredients meet the saved minimum exposure comparison.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 15 Calorie(s) | |
Total Fat | 1.5 Gram(s) | |
Polyunsaturated Fat | 1.5 Gram(s) | |
Cholesterol | 5 mg | |
Fish Oil | 1400 mg | |
Total Omega-3 Fatty Acids Ethyl Esters | 980 mg | |
Eicosapentaenoic Acid | 647 mg | |
Docosahexaenoic Acid | 253 mg | |
Other Omega-3 Fatty Acids | 0 NP |
EPA (Eicosapentaenoic Acid) · 647 mg OverallScore72
A serving provides 647 mg of EPA, about 46.2% of the fish oil. It is in ethyl ester form, and the whole-product serving price works out to about $0.43 per gram of EPA.
How this ingredient is rated
Active Ingredient Quality & Bioavailability48
The EPA is in ethyl ester form. EPA makes up about 46.2% of the 1400 mg of fish oil per serving. Tocopherol is identified as an antioxidant; its presence does not measure the oil’s oxidation.
Molecular Form and Bioavailability
The EPA is in ethyl ester form.
EPA Concentration Density
EPA makes up about 46.2% of the 1400 mg of fish oil per serving.
Oxidation Protection
Tocopherol is identified as an antioxidant; its presence does not measure the oil’s oxidation.
Dose, Safety & Label Transparency82
Each serving has 647 mg of EPA and 253 mg of DHA. The oil is described as purified; a qualifying third-party contaminant-testing claim is not confirmed in the saved information.
Absolute EPA Dose per Serving
Each serving provides 647 mg of EPA, a higher amount.
EPA-Centric Ratio
Each serving has 647 mg of EPA and 253 mg of DHA, so EPA is higher.
Purity and Contaminant Testing
The oil is described as purified; a qualifying third-party contaminant-testing claim is not confirmed in the saved information.
Value100
Based on the whole-product serving price, the cost works out to about $0.43 per gram of EPA.
Price per Gram of EPA
Based on the whole-product serving price, the cost works out to about $0.43 per gram of EPA.
Omega-3 · 980 mg OverallScore74
Fish Oil · 1400 mg OverallScore72
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
- EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
- Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
- Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.